Ever Source Wealth Advisors, LLC Cellectis S.A. Transaction History
Ever Source Wealth Advisors, LLC
- $1.25 Billion
- Q1 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Cellectis S.A. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 13 shares of CLLS stock, worth $25. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 13
-0.0%
Holding current value
$25
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CLLS
# of Institutions
31Shares Held
9.83MCall Options Held
0Put Options Held
30.9K-
Long Focus Capital Management, LLC San Juan, PR4.49MShares$8.75 Million0.64% of portfolio
-
Capital International Investors Los Angeles, CA1.85MShares$3.61 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.44MShares$2.8 Million0.0% of portfolio
-
Baillie Gifford & CO827KShares$1.61 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA425KShares$827,8390.0% of portfolio
About Cellectis S.A.
- Ticker CLLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,510,800
- Market Cap $88.7M
- Description
- Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...